From theheart.org on Medscape

Coverage from the

American College of Cardiology (ACC) 2021 Scientific Session

May 15 - 17, 2021; Virtual

May 15 - 17, 2021 Virtual

MEETING HIGHLIGHTS AT A GLANCE

ACC 2021 Highlights: Drugs and Alcohol Aspirin dosing, alcohol and atrial fibrillation, dual vs mono antiplatelet therapy post PCI, and sacubitril/valsartan post MI are among the drug highlights from ACC 2021.
ACC 2021 Highlights: Non-Drug Approaches Surgical left atrial appendage closure, a novel rehab program, and renal denervation are among the nonpharmacologic highlights from the 2021 American College of Cardiology scientific sessions.

Conference News

ACC 2021 LIFE: ARNI Does Not Best Valsartan in Advanced Heart Failure
Medscape Medical News, June 8, 2021
ACC 2021 Mavacamten Boosts Quality of Life in Hypertrophic Cardiomyopathy
Medscape Medical News, June 7, 2021
ACC 2021 TAILOR-PCI: Genotype-Guided Antiplatelet Therapy Misses Mark
Medscape Medical News, June 4, 2021
ACC 2021 Prediabetes Linked to Higher CVD and CKD Rates
Medscape Medical News, June 3, 2021
ACC 2021 Rivaroxaban Cut Recurrent Limb Events in VOYAGER-PAD
Medscape Medical News, May 31, 2021
ACC 2021 Contentious ISCHEMIA Deep Dive: Extent of Revascularization Key?
Medscape Medical News, May 27, 2021
ACC 2021 Higher, Lower Temps Similar for Hypothermia After Cardiac Arrest
Medscape Medical News, May 25, 2021
ACC 2021 Sotagliflozin's HFpEF Benefit Confirmed by New Analyses
Medscape Medical News, May 24, 2021
ACC 2021 GALACTIC-HF: Novel Drug Most Effective in Sickest HFrEF Patients
Medscape Medical News, May 24, 2021
ACC 2021 Prague OHCA: Hyperinvasive Care, Better Cardiac Arrest Outcomes?
Medscape Medical News, May 22, 2021
ACC 2021 TALOS-AMI: Switching From Ticagrelor to Clopidogrel Safe Post-PCI
Medscape Medical News, May 21, 2021
ACC 2021 New Approach to Heart Failure Targets Myocardial Fibrosis
Medscape Medical News, May 21, 2021
ACC 2021 Even One Drink Doubles Risk for AF Within 4 Hours
Medscape Medical News, May 21, 2021
ACC 2021 SAFE-PAD: Paclitaxel Devices Exonerated in Real-World Data
Medscape Medical News, May 20, 2021
ACC 2021 Early Aspirin Withdrawal After PCI: More Benefit for Women?
Medscape Medical News, May 20, 2021
ACC 2021 Therapeutic Rivaroxaban: Risk Outweighs Benefit in Stable COVID
Medscape Medical News, May 19, 2021
ACC 2021 Novel IL-6 Antibody Slashes CRP up to 92% in High-risk ASCVD
Medscape Medical News, May 18, 2021
ACC 2021 Dapagliflozin Misses in COVID-19 but Intriguing Signal of Benefit
Medscape Medical News, May 18, 2021
ACC 2021 FIDELIO-DKD: Finerenone Cuts New AF in Type 2 Diabetes and CKD
Medscape Medical News, May 18, 2021
ACC 2021 RAFT-AF, Despite Itself, Hints Ablation Advantage in HF With AF
Medscape Medical News, May 17, 2021
ACC 2021 Atorvastatin: A Potential Treatment in COVID-19?
Medscape Medical News, May 17, 2021
ACC 2021 ACC Survey: COVID Slams Already Weary CV Workforce
Medscape Medical News, May 17, 2021
ACC 2021 HOST-EXAM: Clopidogrel Beats Aspirin as Monotherapy After Stenting
Medscape Medical News, May 17, 2021

ACC 2021 Ultrasound Renal Denervation Drops BP in Patients on Triple Therapy
Medscape Medical News, May 16, 2021
ACC 2021 No Advantage for FFR-Guided Complete Revascularization in STEMI
Medscape Medical News, May 16, 2021
ACC 2021 Commission Outlines Plan for Global Fight Against CVD in Women
Medscape Medical News, May 16, 2021
ACC 2021 Novel Rehab Program Fights Frailty, Boosts Capacity in Advanced HF
Medscape Medical News, May 16, 2021
ACC 2021 Nasal Spray Resurrected After Showing Clinical Benefits for PSVT
Medscape Medical News, May 16, 2021
ACC 2021 Follow-up Sinks Candesartan as Cardioprotection in Breast Cancer
Medscape Medical News, May 16, 2021
ACC 2021 TRISCEND: Tricuspid Valve Replacement System Shows Early Promise
Medscape Medical News, May 16, 2021
ACC 2021 New STRENGTH Analysis Reignites Debate on Omega-3 CV Benefits
Medscape Medical News, May 16, 2021
ACC 2021 PARADISE-MI: Sacubitril/Valsartan Can’t Beat Ramipril in Acute MI
Medscape Medical News, May 15, 2021
ACC 2021 Watchman Registry: 1-Year Stroke Estimates Reassuringly Low
Medscape Medical News, May 15, 2021
ACC 2021 ATLANTIS Hints at How to Choose Post-TAVR Antithrombotics
Medscape Medical News, May 15, 2021
ACC 2021 Disadvantaged Patients With CVD Face Barriers to COVID Prevention
Medscape Medical News, May 15, 2021
ACC 2021 LAAOS III: Surgical LAA Closure Cuts AF Stroke Risk by One Third
Medscape Medical News, May 15, 2021
ACC 2021 ADAPTABLE: Low-Dose Aspirin as Good as High-Dose in CHD?
Medscape Medical News, May 15, 2021
ACC 2021 Cardiac Events Doubled Among Distressed Younger Survivors of MI
Medscape Medical News, May 14, 2021
ACC 2021 Advent of hs-Troponins in ED Didn't Lead to Cascades of Testing
Medscape Medical News, May 13, 2021
ACC 2021 AHA/ACC Guidance on Ethics, Professionalism in Cardiovascular Care
Medscape Medical News, May 12, 2021
ACC 2021 Less Care for Young Women With Chest Pain in the Emergency Room?
Medscape Medical News, May 11, 2021
ACC 2021 Moderate Alcohol Tied to Lower Stress-Related Brain Activity, MACE
Medscape Medical News, May 11, 2021
ACC 2021 Revisit of ISCHEMIA Bolsters Conservative Message in Stable CAD
Medscape Medical News, May 10, 2021
ACC 2021 ACC.21 Looks to Repeat Success Despite Pandemic Headwinds
Medscape Medical News, May 10, 2021
ACC 2021 Hypertension Worsened by Commonly Used Prescription Meds
Medscape Medical News, May 7, 2021

© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Perspectives

ACC 2021: What Could Change UK Cardiology Practice?
Dr Sukh Nijjer, BSc, MBChB, MRCP, PhD
LAAOS III Lessons: Surgical Technique and Anticoagulation Key
John M. Mandrola, MD; Richard Whitlock, MD, PhD
REHAB-HF Lays Groundwork for Recovery of Function Post HF
Ileana L. Piña, MD, MPH; Dalane Kitzman, MD
Renal Denervation for Resistant Hypertension Is Not Back on Track
John Mandrola, MD
Acute Alcohol Consumption Raises Risk for Atrial Fibrillation
John M. Mandrola, MD; Gregory M. Marcus, MD, MAS
Sacubitril/Valsartan: Trending Toward PARADISE Post MI?
Ileana L. Piña, MD, MPH; Marc A. Pfeffer, MD, PhD
Does ADAPTABLE Inform Aspirin Dosing for Secondary Prevention?
Michelle L. O'Donoghue, MD, MPH; Schuyler Jones, MD
Eight Things to Know About the LAAOS III Trial
John Mandrola, MD
PARADISE-MI Makes Me Question the Benefits of Sacubitril/Valsartan
John Mandrola, MD
Mandrola Previews (Virtual) ACC 2021
John Mandrola, MD

News from ACC 2020

VICTORIA: Vericiguat Seen as Novel Success in High-Risk HFrEF The relative risk reduction was modest, but experts say the benefit in absolute terms was remarkable for already well-treated patients, who are some of the hardest to keep out of the hospital.
Medscape Medical News, Mar 28, 2020
ISCHEMIA Trials Land in NEJM While ACC.20 Airs Further Insights If there was some skepticism alongside praise when the potentially seismic findings fell upon AHA 2020, will they meet more acceptance now that they are enshrined in a premier journal?
Medscape Medical News, Apr 01, 2020
Renal Denervation Shown Safe and Effective in Pivotal Trial Primary results of the SPYRAL HTN-OFF MED trial showed 'clinically meaningful' blood pressure reductions at 3 months.
Medscape Medical News, Mar 30, 2020

Previous Coverage

Related Resource